US Stock MarketDetailed Quotes

Edgewise Therapeutics (EWTX)

Watchlist
  • 28.610
  • -1.170-3.93%
Close Jan 23 16:00 ET
  • 28.610
  • 0.0000.00%
Post 20:01 ET
3.03BMarket Cap-18.22P/E (TTM)

Edgewise Therapeutics (EWTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-18.58%-109.03M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.1M
-25.29%-28.6M
-74.69%-91.95M
-126.32%-26.83M
Net income from continuing operations
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
Depreciation and amortization
-5.32%570K
6.18%567K
5.52%554K
32.22%2.29M
18.01%629K
21.13%602K
15.84%534K
117.84%525K
221.93%1.73M
479.35%533K
Change In working capital
-128.21%-709K
-180.30%-2.56M
-105.17%-4.76M
762.05%10.33M
3,553.23%6.94M
158.01%2.51M
1,033.63%3.19M
-16.47%-2.32M
-138.18%-1.56M
-103.66%-201K
-Change in prepaid assets
-264.10%-1.3M
-353.02%-2.47M
-2,246.03%-1.48M
192.65%3.29M
518.73%1.59M
168.37%791K
158.93%977K
82.45%-63K
-144.70%-3.55M
-235.84%-379K
-Change in payables and accrued expense
-59.07%778K
-96.02%95K
-48.23%-3.1M
246.02%7.26M
1,615.25%5.06M
-14.91%1.9M
81.38%2.39M
-19.68%-2.09M
-19.90%2.1M
-91.40%295K
-Change in other current liabilities
-5.59%-189K
-9.36%-187K
-9.15%-179K
-111.54%-220K
351.28%294K
-73.79%-179K
---171K
-241.38%-164K
-103.56%-104K
-106.58%-117K
Cash from discontinued investing activities
Operating cash flow
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-18.58%-109.03M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.1M
-25.29%-28.6M
-74.69%-91.95M
-126.32%-26.83M
Investing cash flow
Cash flow from continuing investing activities
40.82%35.72M
-533.97%-162.17M
116.36%43.9M
-279.48%-184.66M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
245.78%102.89M
135.69%26.98M
Net PPE purchase and sale
82.88%-89K
77.38%-50K
85.19%-44K
77.16%-1.31M
-70.19%-274K
-13.79%-520K
70.88%-221K
93.20%-297K
-3.59%-5.75M
95.11%-161K
Net investment purchase and sale
38.34%35.81M
-531.29%-162.12M
116.40%43.94M
-268.78%-183.34M
-21.91%21.2M
8.40%25.88M
794.76%37.59M
-601.80%-268.01M
267.04%108.63M
137.54%27.14M
Cash from discontinued investing activities
Investing cash flow
40.82%35.72M
-533.97%-162.17M
116.36%43.9M
-279.48%-184.66M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
245.78%102.89M
135.69%26.98M
Financing cash flow
Cash flow from continuing financing activities
-50.23%1.66M
9,542.98%188.23M
-99.08%2.22M
368.82%249.25M
-94.54%2.9M
1,679.62%3.33M
429.00%1.95M
1,147,866.67%241.07M
-58.99%53.17M
17,587.46%52.99M
Net common stock issuance
--0
--187.36M
--0
354.50%239.15M
--0
--0
--0
--239.15M
-59.26%52.62M
9,580.72%52.62M
Proceeds from stock option exercised by employees
-53.23%1.66M
-58.45%831K
17.39%2.26M
1,354.14%10.37M
804.69%2.9M
118,133.33%3.55M
442.01%2M
9,071.43%1.93M
-1.66%713K
91.62%320K
Net other financing activities
----
----
---38K
-58.79%-262K
--0
---214K
----
----
34.26%-165K
-42.35%49K
Cash from discontinued financing activities
Financing cash flow
-50.23%1.66M
9,542.98%188.23M
-99.08%2.22M
368.82%249.25M
-94.54%2.9M
1,679.62%3.33M
429.00%1.95M
1,147,866.67%241.07M
-58.99%53.17M
17,587.46%52.99M
Net cash flow
Beginning cash position
-0.19%43.4M
64.95%49.92M
-51.61%41.67M
291.47%86.1M
35.95%44.81M
36.72%43.49M
-37.25%30.26M
291.47%86.1M
41.29%21.99M
-69.97%32.96M
Current changes in cash
96.74%2.6M
-149.29%-6.52M
114.79%8.26M
-169.31%-44.43M
-105.91%-3.14M
14.87%1.32M
180.50%13.22M
-312.80%-55.83M
897.42%64.1M
160.56%53.14M
End cash Position
2.67%46M
-0.19%43.4M
64.95%49.92M
-51.61%41.67M
-51.61%41.67M
35.95%44.81M
36.72%43.49M
-37.25%30.26M
291.47%86.1M
291.47%86.1M
Free cash flow
-24.99%-34.87M
-23.98%-32.63M
-31.20%-37.91M
-12.95%-110.34M
-0.89%-27.23M
-23.89%-27.89M
-25.38%-26.32M
-6.26%-28.9M
-67.91%-97.69M
-78.18%-26.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -27.04%-34.78M-24.84%-32.58M-32.41%-37.87M-18.58%-109.03M-0.47%-26.96M-24.10%-27.37M-28.99%-26.1M-25.29%-28.6M-74.69%-91.95M-126.32%-26.83M
Net income from continuing operations -19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M
Depreciation and amortization -5.32%570K6.18%567K5.52%554K32.22%2.29M18.01%629K21.13%602K15.84%534K117.84%525K221.93%1.73M479.35%533K
Change In working capital -128.21%-709K-180.30%-2.56M-105.17%-4.76M762.05%10.33M3,553.23%6.94M158.01%2.51M1,033.63%3.19M-16.47%-2.32M-138.18%-1.56M-103.66%-201K
-Change in prepaid assets -264.10%-1.3M-353.02%-2.47M-2,246.03%-1.48M192.65%3.29M518.73%1.59M168.37%791K158.93%977K82.45%-63K-144.70%-3.55M-235.84%-379K
-Change in payables and accrued expense -59.07%778K-96.02%95K-48.23%-3.1M246.02%7.26M1,615.25%5.06M-14.91%1.9M81.38%2.39M-19.68%-2.09M-19.90%2.1M-91.40%295K
-Change in other current liabilities -5.59%-189K-9.36%-187K-9.15%-179K-111.54%-220K351.28%294K-73.79%-179K---171K-241.38%-164K-103.56%-104K-106.58%-117K
Cash from discontinued investing activities
Operating cash flow -27.04%-34.78M-24.84%-32.58M-32.41%-37.87M-18.58%-109.03M-0.47%-26.96M-24.10%-27.37M-28.99%-26.1M-25.29%-28.6M-74.69%-91.95M-126.32%-26.83M
Investing cash flow
Cash flow from continuing investing activities 40.82%35.72M-533.97%-162.17M116.36%43.9M-279.48%-184.66M-22.46%20.92M8.30%25.36M985.65%37.37M-647.10%-268.31M245.78%102.89M135.69%26.98M
Net PPE purchase and sale 82.88%-89K77.38%-50K85.19%-44K77.16%-1.31M-70.19%-274K-13.79%-520K70.88%-221K93.20%-297K-3.59%-5.75M95.11%-161K
Net investment purchase and sale 38.34%35.81M-531.29%-162.12M116.40%43.94M-268.78%-183.34M-21.91%21.2M8.40%25.88M794.76%37.59M-601.80%-268.01M267.04%108.63M137.54%27.14M
Cash from discontinued investing activities
Investing cash flow 40.82%35.72M-533.97%-162.17M116.36%43.9M-279.48%-184.66M-22.46%20.92M8.30%25.36M985.65%37.37M-647.10%-268.31M245.78%102.89M135.69%26.98M
Financing cash flow
Cash flow from continuing financing activities -50.23%1.66M9,542.98%188.23M-99.08%2.22M368.82%249.25M-94.54%2.9M1,679.62%3.33M429.00%1.95M1,147,866.67%241.07M-58.99%53.17M17,587.46%52.99M
Net common stock issuance --0--187.36M--0354.50%239.15M--0--0--0--239.15M-59.26%52.62M9,580.72%52.62M
Proceeds from stock option exercised by employees -53.23%1.66M-58.45%831K17.39%2.26M1,354.14%10.37M804.69%2.9M118,133.33%3.55M442.01%2M9,071.43%1.93M-1.66%713K91.62%320K
Net other financing activities -----------38K-58.79%-262K--0---214K--------34.26%-165K-42.35%49K
Cash from discontinued financing activities
Financing cash flow -50.23%1.66M9,542.98%188.23M-99.08%2.22M368.82%249.25M-94.54%2.9M1,679.62%3.33M429.00%1.95M1,147,866.67%241.07M-58.99%53.17M17,587.46%52.99M
Net cash flow
Beginning cash position -0.19%43.4M64.95%49.92M-51.61%41.67M291.47%86.1M35.95%44.81M36.72%43.49M-37.25%30.26M291.47%86.1M41.29%21.99M-69.97%32.96M
Current changes in cash 96.74%2.6M-149.29%-6.52M114.79%8.26M-169.31%-44.43M-105.91%-3.14M14.87%1.32M180.50%13.22M-312.80%-55.83M897.42%64.1M160.56%53.14M
End cash Position 2.67%46M-0.19%43.4M64.95%49.92M-51.61%41.67M-51.61%41.67M35.95%44.81M36.72%43.49M-37.25%30.26M291.47%86.1M291.47%86.1M
Free cash flow -24.99%-34.87M-23.98%-32.63M-31.20%-37.91M-12.95%-110.34M-0.89%-27.23M-23.89%-27.89M-25.38%-26.32M-6.26%-28.9M-67.91%-97.69M-78.18%-26.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More